Search
forLearn
5 / 801 resultslearn Shankh bhasm
learn Shatavari
learn vividine
learn Haritaki
Research
5 / 1000+ results
research Management of Hirsutism Associated With Obese PCOD - A Case Report
Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.
research Ayurvedic management of Alopecia Areata - A Single Case Study
Ayurvedic treatments helped a 16-year-old regrow hair after modern medicine failed.
research Ayurvedic Interventions For PCOS: A Single-Case Analysis
Ayurvedic treatments can help manage PCOS symptoms.
research A MINI REVIEW ON PHOTO- BIOMODULATION- Novel approach
Photobiomodulation therapy shows promise in treating various health conditions by using specific light wavelengths.
research Ayurvedic Management of Seborrheic Dermatitis
Ayurveda offers a safer and effective way to manage Seborrheic dermatitis without severe side effects.
Community Join
5 / 1000+ resultscommunity Kintors 1% Pyrilutamide comes in October/November
Kintor's 1% Pyrilutamide will be released in October/November. The user cannot tolerate finasteride.
community Anagenic is trying to compound Gt20029
The conversation discusses concerns that Anagenic's version of GT20029 might not be as effective or safe as Kintor's, with comparisons to issues faced by pyrilutamide. The chemical structure of the drug has been published.
community Kintor long term safety phase 3
Kintor's phase III trial for pyri (KX-826) showed promising safety and efficacy results, with no drug-related sexual dysfunction reported. Users discussed their experiences with pyri, Minoxidil, Dutasteride, and concerns about the validity of the study results.
community First patient dosed with Pyrilutamide (Kintor) Phase III
First patient dosed with Pyrilutamide (Kintor) Phase III for hair loss treatment. Pyrilutamide differs from approved treatments as it competes with DHT to bind hair follicles, potentially reducing side effects.
community Kintor pyrilutamide presentation?
The conversation is about whether the phase 2 results for pyrilutamide, a potential hair loss treatment, were presented at a dermatology convention and inquiries about the completion of phase 3 trials. Specific treatments mentioned include pyrilutamide.